Vericel (VCEL) Liabilities and Shareholders Equity (2010 - 2026)

Vericel's Liabilities and Shareholders Equity history runs 17 years deep, the most recent figure standing at $485.6 million for Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity rose 14.38% year-over-year to $485.6 million; the TTM figure through Mar 2026 stood at $1.9 billion (up 14.65% YoY), while the FY2025 annual figure was $488.0 million, up 12.77% from the prior year.
• Liabilities and Shareholders Equity came in at $485.6 million for Q1 2026 at Vericel, roughly flat from $488.0 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $488.0 million in Q4 2025 to a low of $240.3 million in Q1 2022.
• A 5-year average of $358.7 million and a median of $356.7 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
• Across the five-year window, Liabilities and Shareholders Equity grew 10.3% in 2022 and surged 34.54% in 2024, its largest moves.
• Vericel's Liabilities and Shareholders Equity stood at $273.0 million in 2022, then rose by 29.54% to $353.7 million in 2023, then gained by 22.36% to $432.7 million in 2024, then advanced by 12.77% to $488.0 million in 2025, then decreased by 0.48% to $485.6 million in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $485.6 million, $488.0 million, and $453.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison